During the past decade, Karlskoga Lasarett conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karlskoga Lasarett" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Karolinska Institutet" with 1 trials as a collaborator and "Linkoeping University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Karlskoga Lasarett" are "Diabetes Mellitus, Type 1" (1 trials), "Hip Arthritis" (1 trials), "Hip Fractures" (1 trials), "Lactation" (1 trials) and "Pregnancy" (1 trials). Many other conditions were trialed in "Karlskoga Lasarett" in a lesser frequency.

Most popular intervention types in "Karlskoga Lasarett" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by ": A support program to facilitate implementation of evidence-based practice for postoperative urinary retention" (1 trials), "Empagliflozin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karlskoga Lasarett" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Karlskoga Lasarett". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Karlskoga Lasarett, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karlskoga Lasarett, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".